Newcells Biotech are experts in the production of induced pluripotent stem cells.
Newcells Biotech has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Newcells Biotech's investors include Northstar Ventures, Mercia Ventures, NVM Private Equity, Mercia Asset Management, North East Fund.
Newcells Biotech is headquartered in Newcastle Upon Tyne, United Kingdom.
Newcells Biotech are experts in the production of induced pluripotent stem cells.
Newcells Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Newcells Biotech — Funding & Investors." VCBacked, December 5, 2024, https://www.vcbacked.co/company/newcells-biotech. Accessed August 14, 2026.
VCBacked. (2024). Newcells Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/newcells-biotech
{{cite web |title=Newcells Biotech — Funding & Investors |url=https://www.vcbacked.co/company/newcells-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated